PORTFOLIO Las Vegas 2024 Pharma & Biotech

13–15 Nov 2024 | Las Vegas, United States

Thursday, 14 November 2024 | 14:00 - 15:00

CASE STUDY: Converting asset strategy into actionable plan using a clinical development plan

Format:In-person
Location:Pavilion 1
Track:
PROJECTS
  • CLINICAL VS. NONCLINICAL PROJECT MANAGEMENT
131 participants

When an executive level governing body provides a high-level and often vague asset strategy, it is up to the Program Manager to help the project team translate that strategy into a clear and actionable Clinical Development Plan (CDP). This session will describe the utility of the CDP, the contents of a CDP, and a process the Program Manager can follow to create a CDP. The CDP then effectively becomes the documentation of aligned expectations between the project team and the governing body.

2 speakers

  • Joe Stalder

    VP Program Management

    Zentalis Pharmaceuticals

  • Stephen Smith

    Senior Program Director, Oncology

    Corcept Therapeutics